Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
pneumococcal 13-valent conjugate vaccine
pneumococcal 13-valent conjugate vaccine
- Restricted Vaccine Formulary
VIEW MORE Vaccines
Last updated: Apr. 19, 2024
PREVNAR-13 is being discontinued by the manufacturer April 30, 2024
Pediatrics: PREVNAR-13 is approved for children age 2 months to 59 months or high risk children 60 months to 71 months, where outpatient administration of the vaccine is not desirable.
Adults: PREVNAR-13 is also approved for use in adults, 19 years and older who have immunocompromised conditions, functional or anatomic asplenia, CSF leaks, or cochlear implants.
Reviewed: November 13, 2012